Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies?
about
Structure-activity relationships of hydroxamate-based histone deacetylase-8 inhibitors: reality behind anticancer drug discovery.Multiple molecular modelling studies on some derivatives and analogues of glutamic acid as matrix metalloproteinase-2 inhibitors.Exploring in house glutamate inhibitors of matrix metalloproteinase-2 through validated robust chemico-biological quantitative approaches
P2860
Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Is dual inhibition of metalloe ...... at hematological malignancies?
@en
type
label
Is dual inhibition of metalloe ...... at hematological malignancies?
@en
prefLabel
Is dual inhibition of metalloe ...... at hematological malignancies?
@en
P1476
Is dual inhibition of metalloe ...... at hematological malignancies?
@en
P2093
P356
10.1016/J.PHRS.2017.05.002
P577
2017-05-10T00:00:00Z